We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
301
Charles Schwab
SCHW
$182B
$5.24M 0.04%
95,359
+114
+0.1% +$6.89K
RAPT
302
DELISTED
RAPT Therapeutics
RAPT
$5.21M 0.04%
39,158
– –
ACGL icon
303
Arch Capital
ACGL
$36.5B
$5.14M 0.04%
64,429
-138,408
-68% -$10.8M
CME icon
304
CME Group
CME
$95.4B
$5.09M 0.04%
25,434
-1,188
-4% -$236K
CWEN icon
305
Clearway Energy Class C
CWEN
$4.79B
$5.08M 0.04%
240,123
-44,738
-16% -$1.14M
AMT icon
306
American Tower
AMT
$83.5B
$5.07M 0.04%
30,852
-601
-2% -$110K
AKRO
307
DELISTED
Akero Therapeutics
AKRO
$5.06M 0.04%
100,000
-15,000
-13% -$698K
HRI icon
308
Herc Holdings
HRI
$4.78B
$4.86M 0.03%
40,837
-24,410
-37% -$3.19M
EXC icon
309
Exelon
EXC
$48.1B
$4.75M 0.03%
125,649
-166
-0.1% -$6.76K
SAGE
310
DELISTED
Sage Therapeutics
SAGE
$4.67M 0.03%
227,000
– –
MPC icon
311
Marathon Petroleum
MPC
$90.1B
$4.67M 0.03%
30,854
-18,345
-37% -$2.56M
PCRX icon
312
Pacira BioSciences
PCRX
$1.04B
$4.66M 0.03%
151,901
-40,000
-21% -$1.44M
FDX icon
313
FedEx
FDX
$73B
$4.63M 0.03%
17,485
+31
+0.2% +$8.06K
EOG icon
314
EOG Resources
EOG
$77.7B
$4.53M 0.03%
35,701
-673
-2% -$85.6K
COO icon
315
Cooper Companies
COO
$14.2B
$4.51M 0.03%
56,672
+21,216
+60% +$1.95M
KHC icon
316
Kraft Heinz
KHC
$32.8B
$4.48M 0.03%
133,323
-37,081
-22% -$1.28M
AIG icon
317
American International
AIG
$42.5B
$4.44M 0.03%
73,239
-1,575
-2% -$94K
KMI icon
318
Kinder Morgan
KMI
$70.9B
$4.44M 0.03%
267,512
-628
-0.2% -$10.8K
TREX icon
319
Trex
TREX
$4.4B
$4.4M 0.03%
71,396
-20,315
-22% -$1.39M
MDGL icon
320
Madrigal Pharmaceuticals
MDGL
$12.6B
$4.24M 0.03%
29,000
– –
CARR icon
321
Carrier Global
CARR
$49.8B
$4.17M 0.03%
75,521
-689
-0.9% -$37.9K
ALV icon
322
Autoliv
ALV
$9.14B
$4.11M 0.03%
42,606
+10,808
+34% +$1.04M
BX icon
323
Blackstone
BX
$104B
$4.1M 0.03%
38,236
-1,014
-3% -$106K
ONT
324
Onterris Inc
ONT
$731M
$4.03M 0.03%
137,775
+55,554
+68% +$2.11M
ULTA icon
325
Ulta Beauty
ULTA
$21.8B
$3.97M 0.03%
9,951
+7,069
+245% +$3.09M
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.